Exact Mass: 444.1199

Exact Mass Matches: 444.1199

Found 52 metabolites which its exact mass value is equals to given mass value 444.1199, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Seladelpar

C21H23F3O5S (444.1218)

C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites Seladelpar (MBX-8025) is an orally active, potent (50\% effect concentration EC50 2 nM), and specific PPAR-δ agonist[1][2].

5-O-[(R)-Hydroxy{[(2s)-Pyrrolidin-2-Ylcarbonyl]oxy}phosphoryl]adenosine

C15H21N6O8P (444.1158)

Artomunoxanthentrione

11-hydroxy-19-methoxy-7,7-dimethyl-16-(prop-1-en-2-yl)-2,8-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-1(22),3(12),4(9),5,10,14,16,19-octaene-13,18,21-trione

C26H20O7 (444.1209)

Artomunoxanthentrione is found in breadfruit. Artomunoxanthentrione is a constituent of Artocarpus communis (breadfruit). Constituent of Artocarpus communis (breadfruit). Artomunoxanthentrione is found in breadfruit and fruits.

4-Hydroxyphenytoin glucuronide

(2S,3S,4S,5R)-6-[4-(2,5-dioxo-4-phenylimidazolidin-4-yl)phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C21H20N2O9 (444.1169)

4-Hydroxyphenytoin glucuronide is a metabolite of phenytoin. Phenytoin sodium is a commonly used antiepileptic. Phenytoin acts to suppress the abnormal brain activity seen in seizure by reducing electrical conductance among brain cells by stabilizing the inactive state of voltage-gated sodium channels. Aside from seizures, it is an option in the treatment of trigeminal neuralgia in the event that carbamazepine or other first-line treatment seems inappropriate. It is sometimes considered a class 1b antiarrhythmic. (Wikipedia)

Seladelpar

2-[4-({2-ethoxy-3-[4-(trifluoromethyl)phenoxy]propyl}sulphanyl)-2-methylphenoxy]acetic acid

C21H23F3O5S (444.1218)

Defibrotide

{5-hydroxy-4-[4-(1-methyl-1H-indol-5-yl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]-2-(propan-2-yl)phenoxy}phosphonic acid

C20H21N4O6P (444.1199)

Kottamide C

C21H25BrN4O2 (444.1161)

Kottamide B

C21H25BrN4O2 (444.1161)

Artomunoxanthentrione

6-Hydroxy-11-methoxy-3,3-dimethyl-9- (1-methylethenyl) -3H,7H-benzo [ c ] pyrano [ 3,2-h ] xanthene-7,10,13-trione

C26H20O7 (444.1209)

DODECAMETHYLCYCLOHEXASILOXANE

C12H36O6Si6 (444.1127)

D001697 - Biomedical and Dental Materials

Cys Cys Gly Tyr

(2S)-2-{2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetamido}-3-(4-hydroxyphenyl)propanoic acid

C17H24N4O6S2 (444.1137)

Cys Cys Tyr Gly

2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]acetic acid

C17H24N4O6S2 (444.1137)

Cys Gly Cys Tyr

(2S)-2-[(2R)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C17H24N4O6S2 (444.1137)

Cys Gly Tyr Cys

(2R)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanoic acid

C17H24N4O6S2 (444.1137)

Cys Tyr Cys Gly

2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]acetic acid

C17H24N4O6S2 (444.1137)

Cys Tyr Gly Cys

(2R)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]acetamido}-3-sulfanylpropanoic acid

C17H24N4O6S2 (444.1137)

Gly Cys Cys Tyr

(2S)-2-[(2R)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C17H24N4O6S2 (444.1137)

Gly Cys Tyr Cys

(2R)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanoic acid

C17H24N4O6S2 (444.1137)

Gly Tyr Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C17H24N4O6S2 (444.1137)

p-Hydroxyphenytoin glucuronide

C21H20N2O9 (444.1169)

Tyr Cys Cys Gly

2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetic acid

C17H24N4O6S2 (444.1137)

Tyr Cys Gly Cys

(2R)-2-{2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanoic acid

C17H24N4O6S2 (444.1137)

Tyr Gly Cys Cys

(2R)-2-[(2R)-2-{2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]acetamido}-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C17H24N4O6S2 (444.1137)

Titanium acetylacetonate

C20H28O8Ti (444.1264)

4-(2,2-DIPHENYLPROPANE-4-YLOXYSULFONYL) NAPHTHOQUINONE-1,2-DIAZIDE

C25H20N2O4S (444.1144)

ETHYL 4,4,4-TRIFLUORO-2-(TRIPHENYLPHOSPHORANYLIDENE)ACETOACETATE

C24H20F3O3P (444.1102)

Defibrotide

Defibrotide sodium

C20H21N4O6P (444.1199)

B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

(6-fluoro-2-methyl-3,4-dihydro-2H-quinolin-1-yl)-[5-(2-furanyl)-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinyl]methanone

C22H16F4N4O2 (444.1209)

(2r,3s,4s,7s,8s,9s,10s,11s)-7-(chloromethyl)-3,7,10-trihydroxy-2,11-dimethyl-6,12-dioxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradec-1(13)-en-9-yl (2e)-2-methylbut-2-enoate

C20H25ClO9 (444.1187)

7-(chloromethyl)-3,7,10-trihydroxy-2,11-dimethyl-6,12-dioxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradec-1(13)-en-9-yl 2-methylbut-2-enoate

C20H25ClO9 (444.1187)

(2r,3s,4s,7s,8s,9s,10s,11s)-7-(chloromethyl)-3,7,10-trihydroxy-2,11-dimethyl-6,12-dioxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradec-1(13)-en-9-yl (2z)-2-methylbut-2-enoate

C20H25ClO9 (444.1187)

(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(2r)-2-hydroxy-3-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}propoxy]oxane-2-carboxylic acid

C19H24O12 (444.1268)